insight
✂️ 성형 🏥 중증 🌐 전체
← 뒤로

A comparison of pulmonologist-led biopsy techniques for histological subtyping and molecular profiling in non-small-cell lung cancer.

1/5 보강
Respiratory medicine 2025 Vol.250() p. 108535
Retraction 확인
출처
PubMed DOI

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
786 cases, 750 (95 %) had confirmed NSCLC histological diagnosis on biopsy specimens.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
However, endobronchial and neck node biopsies provided less complete diagnostic information compared to other modalities. This study demonstrates that pulmonologist-led standard biopsy techniques perform well in informing on treatment-predictive biomarkers for NSCLC.

Arooj P, Hassan M, Rai H, Zaki I, Syred K, Hadden R, Farrugia J, Taylor L, Howell T, Nicholson T, Corcoran J, Daneshvar C

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.7%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓
📝 환자 설명용 한 줄

[INTRODUCTION] Pulmonologist-led biopsy techniques are essential for lung cancer diagnosis and comprehensive profiling of actionable therapeutic targets.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value p < 0.001

이 논문을 인용하기

↓ .bib ↓ .ris
APA Arooj P, Hassan M, et al. (2025). A comparison of pulmonologist-led biopsy techniques for histological subtyping and molecular profiling in non-small-cell lung cancer.. Respiratory medicine, 250, 108535. https://doi.org/10.1016/j.rmed.2025.108535
MLA Arooj P, et al.. "A comparison of pulmonologist-led biopsy techniques for histological subtyping and molecular profiling in non-small-cell lung cancer.." Respiratory medicine, vol. 250, 2025, pp. 108535.
PMID 41290120 ↗
DOI 10.1016/j.rmed.2025.108535

Abstract

[INTRODUCTION] Pulmonologist-led biopsy techniques are essential for lung cancer diagnosis and comprehensive profiling of actionable therapeutic targets. This study compares the diagnostic outcomes of these techniques in providing histological and therapeutic target information in patients with non-small cell lung cancer (NSCLC).

[METHODS] We retrospectively reviewed patients diagnosed with NSCLC from October 2014 to September 2021 who underwent flexible bronchoscopy (FOB), endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA), ultrasound-guided (USG) biopsies (neck, chest wall, lung, pleura), and local anaesthetic thoracoscopy (LAT). Primary outcomes included the adequacy of specimens across different diagnostic modalities for NSCLC subtyping and therapeutic target profiling, with completion of all requested tests. Secondary outcomes assessed factors predictive of achieving histological and molecular diagnosis.

[RESULTS] Of 786 cases, 750 (95 %) had confirmed NSCLC histological diagnosis on biopsy specimens. Samples were sufficient for NSCLC subtyping in 89-100 % of cases, with NSCLC adenocarcinoma diagnosed in 60 %. EBUS-TBNA, USG biopsies, and LAT outperformed FOB endobronchial and USG neck node biopsies for subtyping (p < 0.001). Therapeutic target testing success ranged from 88 to 100 %, with higher failure rates in FOB (20-30 %) and neck node biopsies (18-19 %) compared to EBUS-TBNA (8.1 %) and other modalities (4-10 %). Successful completion in all requested tests was less likely in patients undergoing FOB and neck nodal biopsies.

[CONCLUSIONS] Pulmonologist-led biopsies yielded high success in histological profiling and identifying predictive biomarkers. However, endobronchial and neck node biopsies provided less complete diagnostic information compared to other modalities. This study demonstrates that pulmonologist-led standard biopsy techniques perform well in informing on treatment-predictive biomarkers for NSCLC.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반